Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Vascular Medicine (London, England)
|
July 7, 2019
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease
Kerry S Russell, Denise P Yates, Christopher M Kramer, et al.
The Annals of Thoracic Surgery
|
July 5, 2011
Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms
Dorinna D Mendoza, Minisha Kochar, Richard B Devereux, et al.
Nature Genetics
|
October 19, 2004
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy
Brenda Gerull, Arnd Heuser, Thomas Wichter, et al.
American Heart Journal
|
October 11, 2011
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from phase I and scientific opportunities in phase II
Barbara L Kroner, H Eser Tolunay, Craig T Basson, et al.
Pediatric Research
|
September 27, 2005
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome
Deborah A McDermott, Michael C Bressan, Jie He, et al.
The Annals of Thoracic Surgery
|
August 25, 2009
Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions
Howard K Song, Joseph E Bavaria, Mark W Kindem, et al.
Journal of the American College of Cardiology
|
June 11, 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry
Jonathan W Weinsaft, Richard B Devereux, Liliana R Preiss, et al.
Blood
|
January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
Alexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Lancet (London, England)
|
May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
Beryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Circulation
|
August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
Zhen Guo, Anahita Ataran, Pan Ma, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Vascular Medicine (London, England)
|
July 7, 2019
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease
Kerry S Russell, Denise P Yates, Christopher M Kramer, et al.
The Annals of Thoracic Surgery
|
July 5, 2011
Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms
Dorinna D Mendoza, Minisha Kochar, Richard B Devereux, et al.
Nature Genetics
|
October 19, 2004
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy
Brenda Gerull, Arnd Heuser, Thomas Wichter, et al.
American Heart Journal
|
October 11, 2011
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from phase I and scientific opportunities in phase II
Barbara L Kroner, H Eser Tolunay, Craig T Basson, et al.
Pediatric Research
|
September 27, 2005
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome
Deborah A McDermott, Michael C Bressan, Jie He, et al.
The Annals of Thoracic Surgery
|
August 25, 2009
Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions
Howard K Song, Joseph E Bavaria, Mark W Kindem, et al.
Journal of the American College of Cardiology
|
June 11, 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry
Jonathan W Weinsaft, Richard B Devereux, Liliana R Preiss, et al.
Blood
|
January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
Alexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Lancet (London, England)
|
May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
Beryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Circulation
|
August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
Zhen Guo, Anahita Ataran, Pan Ma, et al.
Page
of 5